(2R)-2-phenyl-2-(propanoylamino)acetic acid | 1260102-62-2

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (2R)-2-phenyl-2-(propanoylamino)acetic acid
• CAS: 1260102-62-2
• 化学式: C₁₁H₁₃NO₃
• 分子量: 207.229
• InChiKey: HVTUONCHNDNNHF-SNVBAGLBSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  15
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  66.4
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  N-丙酰-DL-苯基甘氨酸 在 苯基甘氨酸甲酯 、 盐酸 作用下， 以 水 为溶剂， 反应 4.0h， 生成 (2R)-2-phenyl-2-(propanoylamino)acetic acid 、 (2S)-2-phenyl-2-propanamidoacetic acid
  参考文献：
  名称：

  The influence of molecular structure and crystallization time on the efficiency of diastereoisomeric salt forming resolutions

  摘要：

  Reciprocal resolutions between compounds (racemates and enantiomers) with similar structures have been examined. Amongst structurally similar compounds (so called relative structures) several N-acyl amino acids and amino acid esters were investigated. A part of the resolving agent or the racemic compound could be replaced by an achiral compound with a relative structure and an additive could occasionally improve significantly the efficiency of the resolution. Both the kinetic and the thermodynamic controls were observed as governing factors of the reciprocal resolutions. (C) 2010 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetasy.2010.09.005

文献信息

• SULFONYLETHYL PHOSPHORODIAMIDATES
  申请人：Allen R. David

  公开号：US20080039429A1

  公开（公告）日：2008-02-14

  Sulfonylethyl and thioethyl phosphorodiamidates, their preparation and intermediates in their preparation, formulations containing them, and their pharmaceutical use. The compounds are useful for treating cancer, alone and in combination with other anticancer therapies.

  Sulfonylethyl和thioethyl磷酰二胺酸酯，它们的制备及其制备中间体，含有它们的制剂，以及它们的药物用途。这些化合物可用于治疗癌症，单独或与其他抗癌疗法结合使用。
• ANTIVIRAL COMPOUNDS
  申请人：GILEAD PHARMASSET LLC

  公开号：US20150353529A1

  公开（公告）日：2015-12-10

  The invention is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.

  本发明涉及抗病毒化合物、含有这种化合物的组合物、包括给予这种化合物的治疗方法，以及用于制备这种化合物的过程和中间体。
• Antiviral compounds
  申请人：GILEAD PHARMASSET LLC

  公开号：US10344019B2

  公开（公告）日：2019-07-09

  The invention is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.

  本发明涉及抗病毒化合物、含有此类化合物的组合物、包括施用此类化合物的治疗方法，以及制备此类化合物的工艺和中间体。
• US7262182B2
  申请人：——

  公开号：US7262182B2

  公开（公告）日：2007-08-28
• US8093231B2
  申请人：——

  公开号：US8093231B2

  公开（公告）日：2012-01-10